Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
Vulvar cancer often starts with symptoms that look like common skin or gynecological problems, which can delay diagnosis. Early detection is important for better outcomes. Symptoms happen because the cancer disrupts the skin and nerves of the vulva. The causes are complex, involving infections, long-term inflammation, and genetics. It’s important to take persistent vulvar symptoms seriously, as they may signal early cancer changes.
The most common symptom of vulvar cancer is ongoing itching that does not go away with usual treatments. As the cancer grows, a lump or sore may appear, which can look like a wart or ulcer. Pain, tenderness, bleeding, or unusual discharge are also common, especially as the tumor affects nerves and blood vessels. In advanced cases, problems with urination or rectal bleeding can occur if nearby areas are involved.
The sensation of itch in vulvar cancer is not merely a surface phenomenon but a complex neuroimmunological event. In the context of Lichen Sclerosus-associated cancers, chronic inflammation leads to the release of cytokines, such as interleukin-31 and histamine, which directly stimulate C nerve fibers. As the epithelium becomes dysplastic, the architecture of these nerve endings is altered. The transition from itch to pain marks a critical threshold, often indicating tumor invasion into the deep dermis and the perineural space. Tumor cells secrete neurotrophic factors, such as Nerve Growth Factor, which promote the sprouting of new nerve fibers and sensitize pain receptors, leading to the severe, burning pain often described by patients with invasive disease.
Chronic inflammation is the engine driving the HPV independent pathway of vulvar cancer. Lichen Sclerosus is the archetype of this inflammatory carcinogenesis. It is an autoimmune condition characterized by a T-cell-mediated attack on the basal layer of the epidermis. This persistent autoimmune assault creates an environment of oxidative stress, in which free radicals damage the DNA of regenerating epithelial cells. The body’s attempt to repair this damage leads to a hyperproliferative state. Over decades, this cycle of damage and repair exhausts the genomic safeguards, leading to the accumulation of driver mutations, particularly in TP53. This mechanism is analogous to a wound that never heals, where the reparative process itself becomes the seed of malignancy.
Molecular Signaling and Carcinogenic Exposure
Human Papillomavirus (HPV) is the main cause of certain types of vulvar cancer, especially the basaloid and warty types. HPV spreads through skin-to-skin sexual contact. Most infections go away on their own, but if high-risk types like HPV 16 or 18 persist, they can cause cancer by changing the DNA of vulvar cells. Smoking, HIV, and long-term steroid use make it harder for the body to clear HPV, increasing cancer risk.
Beyond local conditions, systemic factors play a role in etiology. Immunosuppression is a profound risk factor. Patients with HIV AIDS, or those receiving immunosuppressive therapy for organ transplants or autoimmune diseases, have a significantly elevated risk of developing HPV associated vulvar cancers. The immune system’s failure to control viral replication allows rapid progression from dysplasia to carcinoma. Additionally, a history of other lower genital tract neoplasias is a strong predictor of risk, reflecting the field effect, in which the entire anogenital epithelium has been exposed to the same carcinogenic insults. Genetic susceptibility, while less defined than in breast or ovarian cancer, may involve polymorphisms in genes regulating the immune response to HPV or the metabolism of carcinogens.
Systemic Risk Factors and Comorbidities
While squamous cell carcinoma is the dominant type, the causes of non-squamous vulvar cancers are distinct. Vulvar melanoma arises from the malignant transformation of melanocytes. Unlike cutaneous melanoma, UV radiation is not a primary cause; instead, genetic mutations in the c KIT and BRAF pathways drive these mucosal melanomas. Extramammary Paget disease is often a primary cutaneous adenocarcinoma. Still, it can occasionally be a manifestation of an underlying internal malignancy, such as colorectal or bladder cancer, spreading to the skin, a phenomenon known as secondary Paget disease. Understanding these distinct etiologies is crucial for accurate diagnosis and management, as the treatment for a glandular tumor differs radically from that of a squamous one.
Send us all your questions or requests, and our expert team will assist you.
The most common early warning sign is persistent itching (pruritus) that does not improve with creams or hygiene changes. Other signs include a change in skin color, such as lighter or darker patches, a lump or wart-like growth, thickening of the skin, or an open sore or ulcer that persists for more than a month.
Smoking is a significant risk factor, particularly for HPV associated vulvar cancer. The carcinogens in tobacco smoke are absorbed into the bloodstream and secreted in the mucus of the genital tract, where they damage the DNA of vulvar cells and suppress the local immune system’s ability to clear the HPV virus.
Yes, although rare, vulvar melanoma can develop from existing moles or nevi or arise de novo from pigment cells in the vulvar skin. Any mole on the vulva that changes in size, shape, or color, or begins to bleed or itch, should be evaluated immediately, as mucosal melanomas can be aggressive.
Most vulvar cancers are not considered hereditary in the same way as breast or ovarian cancer involving BRCA mutations. However, a genetic predisposition to clearing HPV infection or autoimmune conditions like Lichen Sclerosus can run in families, indirectly influencing the risk. Rare conditions like Fanconi Anemia do carry a direct genetic risk.
Lichen Sclerosus causes chronic inflammation and rapid cell turnover as the skin attempts to heal itself. This constant cycle of damage and repair increases the likelihood of a genetic mutation in skin cells. Over many years, these mutations can accumulate, leading to the development of squamous cell carcinoma.
Your Comparison List (you must select at least 2 packages)
